Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - PTC Therapeutics
 More »

  • Roche Pays PTC $10M in Spinal Muscular Atrophy Collaboration
    PTC Therapeutics just selected a development candidate in its spinal muscular atrophy (SMA) collaboration with Roche and the SMA Foundation, triggering a $10 million payment to PTC ...
    8-8-2013
  • People in the News
    Shane Kovacs joined PTC Therapeutics as CFO...Prime Therapeutics named Scott Fries as svp of government programs...Novasep hired Udo Steinhauer as fine chemicals market director. ...
    7-10-2013
  • Gene Editing to Treat Genetic Diseases, Part II
    Last week, Part I of this two-part series of articles focused on gene editing strategies involving PTC Therapeutics' small molecule drug candidate PTC124 (ataluren), which acts, ...
    6-20-2013
  • Gene Editing with Multiple Molecular Means
    A completely novel approach to treating this disease has emerged from post-transcriptional control processes. PTC Therapeutics says it applies its proprietary technologies and ...
    6-12-2013
  • GEN | Biolinks
    ... Sciences Corporation Protein Simple ProteoNic BV Proterro, Inc PsychoGenics Inc. PTC Therapeutics, Inc Purdue Pharma, LP Purdue University Q Therapeutics, Inc Qiagen QRxPharma ...
  • People in the News
    named Daniel S. Lynch executive chairman...Aegis Sciences hired Frank Moser as president...PTC Therapeutics appointed Geoffrey McDonough, M.D. , to its board of directors. ...
    12-1-2012
  • People in the News
    ... Alan J. Tuchman, M.D. , joined Oncolytics Biotech as CMO. Jerome B. Zeldis, M.D., Ph.D. PTC Therapeutics appointed Jerome B. Zeldis, M.D., Ph.D. , to its board of directors. Dr. ...
    11-1-2012
  • People in the News
    QPharma promoted Prajeep Kumar Thottupurath to CIO...Bicycle Therapeutics appointed Rolf H. Günther, M.D., Ph.D. , as CEO...PTC Therapeutics promoted Claudia Hirawat to president ...
    5-15-2012
  • Roche Nabs PTC's SMA Program for $30M Up Front
    Roche is paying PTC Therapeutics $30 million up front for an exclusive, worldwide license to the latter's spinal muscular atrophy (SMA) program. It includes three preclinical-stage ...
    11-29-2011
  • AstraZeneca and PTC Ally On Small Molecule Drugs against Cancer
    AstraZeneca and PTC Therapeutics will collaborate on the development of new therapies based on the latter's GEMS(tm) (Gene Expression Modulation by Small-Molecules) platform. The ...
    6-29-2011
  • PTC Therapeutics Receives $1.6M from FDA Orphan Drug Grant
    PTC Therapeutics obtained a $1.6 million grant from the FDA Office of Orphan Products Development to support a Phase III study of ataluren in patients with nonsense mutation cystic ...
    9-21-2010
  • Gains Steadily Building in Biotech Sector
    ... PTC Therapeutics' exclusive research collaboration and licensing agreement with Roche for ... Nektar Therapeutics signed a worldwide licensing agreement with AstraZeneca for two of its ...
    11-1-2009
  • Roche Pays PTC $12M Up Front in CNS Drug Discovery Collaboration
    Roche is paying PTC Therapeutics $12 million up front as part of an agreement to develop small molecule CNS disease drugs. PTC separately announced that Celgene exercised its ...
    9-2-2009
  • Innovative Drug Screening Methodologies
    ... An example of how these concerns were realized comes from studies on PTC124 (from PTC Therapeutics), which is believed to suppress nonsense codons. Duchenne muscular dystrophy and ...
    8-1-2009
  • Spinal Muscular Atrophy Foundation Gives PTC Therapeutics $8...
    The Spinal Muscular Atrophy (SMA) Foundation agreed to fund another round of research at PTC Therapeutics with $8.5 million. This is the second continuation of the collaboration, ...
    5-12-2009

  • Journal Articles

  • Increasing Prevalence of Papillary Thyroid Carcinoma in Recent...
    Maria Alevizaki, George Papageorgiou, Gianna Rentziou, Katerina Saltiki, Panagiota Marafelia, Eleni Loukari, Dimitrios A. Koutras, Meletios-Athanassios Dimopoulos
    Thyroid
    DTC cases (83% papillary [PTC], 17% follicular [FTC] carcinoma) presented in the Endocrine Unit of the Department of Clinical Therapeutics in Alexandra Hospital (18.8% ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll